Articles

A low-cost index strategy tracking stocks with the highest risk-weighted returns has fared well during a period of high inflation and “clear, defined leadership” for the technology sector.

More than three out of four young adults prescribed GLP-1 drugs last year were women, new research shows–raising questions about how societal views of women’s weight may influence use of these medications and underscoring the need to better understand how the drugs may affect fertility, pregnancy, and longer-term health outcomes, researchers say.

Existing-home sales fell to a rate of 4.14 million in April, the National Association of Realtors said.

BuzzFeed’s stock soared on heavy volume Wednesday, after the Vivek Ramaswamy, a former presidential candidate, disclosed that he took a large equity stake in the digital news service.

Anglo American on Wednesday said it has received, and rejected, a third conditional offer from BHP Group, though it’s agreed to push back the deadline for its suitor to make a formal bid.

The FCA has approved asset manager Wisdom Tree’s plans to launch the U.K. first ever physically-backed crypto exchange-traded product

Nearly 100 trading days into 2024, just nine days account for all the S&P 500’s year-to-date gains — and then some. Two themes are key drivers, a top Wall Street analyst says.

Will AI help people navigate an increasingly difficult housing market?

KBW’s David Konrad said the bank’s caution on stock buybacks has overshadowed its boosted net interest income view.

Williams-Sonoma Inc.’s stock WSM rose 8% early Wednesday and was headed for a fresh record, after the upscale home goods retailer crushed profit estimates for the first quarter while revenue also came in ahead of consensus.

Biogen Inc. said Wednesday it’s acquiring privately held Human Immunology Biosciences for $1.15 billion upfront and up to $650 million in potential milestone payments in a move aimed at bolstering its immunology portfolio.

Rival brokerage Robinhood says it has seen an influx of new customers since TD Ameritrade users were transitioned to Charles Schwab.